
Hualan Biological Bacterin Inc.
SZSE:301207.SZ
27.9 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|---|
Operating Activities: | ||||||||
Net Income
| 205.515 | 859.969 | 519.635 | 620.972 | 924.909 | 375.298 | 270.148 | -76.882 |
Depreciation & Amortization
| 142.05 | 144.858 | 135.433 | 68.929 | 40.845 | 34.057 | 26.673 | 33.8 |
Deferred Income Tax
| 0 | 0 | -21.748 | -10.268 | -83.702 | 0 | 0 | 0 |
Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change In Working Capital
| 153.911 | -299.378 | -496.827 | -232.944 | -341.005 | -178.813 | -211.808 | 35.919 |
Accounts Receivables
| 884.473 | -224.187 | -380.755 | 89.379 | -906.297 | 0 | 0 | 0 |
Inventory
| -97.316 | -101.742 | -211.487 | -195.391 | -20.174 | -26.936 | -21.351 | -16.709 |
Accounts Payables
| 0 | 170.281 | 117.163 | -116.664 | 669.167 | 0 | 0 | 0 |
Other Working Capital
| -633.246 | -143.731 | -21.748 | -10.268 | -83.702 | -151.877 | -190.456 | 52.628 |
Other Non Cash Items
| -33.435 | 182.576 | 130.421 | 112.372 | 68.963 | 44.5 | 9.443 | 29.334 |
Operating Cash Flow
| 468.041 | 888.025 | 288.662 | 569.329 | 693.712 | 275.041 | 94.456 | 22.172 |
Investing Activities: | ||||||||
Investments In Property Plant And Equipment
| -51.596 | -62.601 | -92.647 | -636.06 | -532.284 | -143.894 | -62.768 | -25.598 |
Acquisitions Net
| 0 | 0 | 0.312 | 0 | 532.285 | 143.894 | 62.843 | 25.857 |
Purchases Of Investments
| -19,438.093 | -4,858.122 | -6,820.193 | -3,584.421 | -2,516.805 | -1,124.784 | -473.114 | -613.9 |
Sales Maturities Of Investments
| 19,428.566 | 4,146.917 | 5,156.878 | 3,128.615 | 2,295.763 | 1,128.162 | 556.994 | 698.251 |
Other Investing Activites
| 0.043 | 0.092 | 0 | 0 | -532.284 | -143.894 | -62.768 | 0.259 |
Investing Cash Flow
| -61.08 | -773.715 | -1,755.651 | -1,091.866 | -753.326 | -140.516 | 21.187 | 59.012 |
Financing Activities: | ||||||||
Debt Repayment
| 0 | 0 | -200 | 300 | 200 | 0 | 0 | 0 |
Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| -334.317 | -126.086 | -90.881 | -12.766 | -4.588 | 0 | 0 | -100 |
Other Financing Activities
| -90.506 | 0 | 2,243.118 | -1.1 | -59.719 | -0 | 0 | 0 |
Financing Cash Flow
| -424.822 | -126.086 | 1,952.237 | 286.134 | 135.693 | -0 | 0 | -100 |
Other Information: | ||||||||
Effect Of Forex Changes On Cash
| -0.084 | 0.114 | 0 | 0 | 0 | -0 | -0 | 0.013 |
Net Change In Cash
| -17.945 | 40.938 | 485.249 | -236.403 | 76.079 | 134.525 | 115.642 | -18.804 |
Cash At End Of Period
| 623.035 | 640.98 | 600.042 | 114.793 | 351.196 | 275.117 | 140.592 | 24.949 |